cutaneous lupus erythematosus - Health Topics
Yahoo Finance: Biogen to Present New Late-Breaking Litifilimab Phase 2 AMETHYST Data in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting Late-breaking AMETHYST Part A study results to be presented, showing safety and efficacy of litifilimab in cutaneous lupus erythematosus (CLE)Litifilimab was recently granted Breakthrough Therapy ... Biogen to Present New Late-Breaking Litifilimab Phase 2 AMETHYST Data in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting Lupus Foundation of America: Survey Highlights the Significant Impact of Cutaneous Lupus Erythematosus on People’s Lives Survey Highlights the Significant Impact of Cutaneous Lupus Erythematosus on People’s Lives Lupus erythematosus is a heterogeneous autoimmune disorder that frequently manifests with distinctive cutaneous involvement. The cutaneous lesions, which range from a malar rash to more indurated, ...
Understanding the Context
Atherosclerotic cardiovascular disease (ASCVD) risk is higher with cutaneous lupus erythematosus (CLE) or systemic lupus erythematosus (SLE) than with psoriasis. A retrospective matched longitudinal ... Yahoo Finance: Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant ... Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant ...
Image Gallery
Key Insights
MarketWatch: Lupus Research Alliance Applauds U.S. FDA Breakthrough Therapy Designation for Litifilimab in Cutaneous Lupus Erythematosus Lupus Research Alliance Applauds U.S. FDA Breakthrough Therapy Designation for Litifilimab in Cutaneous Lupus Erythematosus Newswire: Saphnelo® subcutaneous approved in Canada for the treatment of systemic lupus erythematosus Saphnelo® subcutaneous approved in Canada for the treatment of systemic lupus erythematosus Cutaneous vasculitis (CV) is a term used for inflammation of the blood vessels in the skin that occurs in up to 70% of patients with lupus erythematosus (LE). The inflammation affects the smaller ... Healio: Lupus erythematosus skin disease does not impact severity of systemic lupus Please provide your email address to receive an email when new articles are posted on .
Related Articles You Might Like:
why am i so hungry all of the time best injection site for zepbound remedies for acid reflux diseaseFinal Thoughts
Patients with cutaneous lupus were 1.72 times more likely to have cardiovascular disease than matched controls.